Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma

被引:2
|
作者
Peller, S [1 ]
Halperin, R
Schneider, D
Kopilova, Y
Rotter, V
机构
[1] Assaf Harofeh Med Ctr, Dept Hematol, IL-70300 Zerifin, Israel
[2] Assaf Harofeh Med Ctr, Dept Gynecol, IL-70300 Zerifin, Israel
[3] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel
关键词
p53 tumor suppressor gene; p53; polymorphism; ovarian carcinoma; endometrial; carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p53 gene is frequently mutated in various human tumors. Polymorphism is an additional genetic alteration observed in exons and introns of the p53 gene of normal tissues and tumors. Distributions of alleles of three common polymorphisms of the p53 gene; a 16 bp duplication in intron 3, codon 72 of exon 4 and a sequence in intron 6, were studied in peripheral white blood cells (WBC) of patients with ovarian or endometrial carcinomas. The analysis was performed by PCR and direct sequencing. The 100% linkage observed between the most common haplotypes of each polymorphism in healthy subjects was lower in the patients. A significant difference was observed between frequencies of genotype and haplotype combinations in patients with ovarian carcinoma and endometrial carcinoma. The incidence of heterozygosity was increased in ovarian carcinoma and decreased in endometrial carcinoma. Our results suggest that the p53 gene may be involved in susceptibility and predisposition to various cancers not only by mutations but also by preferential presentation of polymorphic alleles.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 50 条
  • [21] The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma
    Shahin, MS
    Hughes, JH
    Sood, AK
    Buller, RE
    CANCER, 2000, 89 (09) : 2006 - 2017
  • [22] Ovarian cancer linked to p53 gene
    Mayor, S
    BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7100): : 77 - 77
  • [23] Overexpression of p53 in the endometrial gland in postmenopausal women
    Koi, Chiho
    Hachisuga, Toru
    Murakami, Midori
    Kurita, Tomoko
    Thuy Thi Nguyen
    Shimajiri, Shohei
    Fujino, Yoshihisa
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (01): : 104 - 107
  • [24] P53, p21, and p73 gene polymorphisms in gastric carcinoma in Japan
    Shirai, Osamu
    Ohmiya, Naoki
    Taguchi, Ayurnu
    Itoh, Akihiro
    Hirooka, Yoshiki
    Niwa, Yasumasa
    Maeda, Osamu
    Ando, Takaftimi
    Goto, Hiderm
    GASTROENTEROLOGY, 2008, 134 (04) : A609 - A609
  • [25] Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma
    Sakuragi, N
    Hirai, A
    Tada, M
    Yamada, H
    Yamamoto, R
    Fujimoto, S
    Moriuchi, T
    GYNECOLOGIC ONCOLOGY, 2001, 83 (03) : 485 - 490
  • [26] VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells
    T. Fujisawa
    J. Watanabe
    Y. Kamata
    M. Hamano
    H. Hata
    H. Kuramoto
    Human Cell, 2003, 16 (1) : 47 - 54
  • [27] p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer
    Roh, JW
    Kim, JW
    Park, NH
    Song, YS
    Park, IA
    Park, SY
    Kang, SB
    Lee, HP
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 499 - 505
  • [28] Analysis of p53 gene polymorphisms in Romanian patients with squamous cell oesophageal carcinoma
    Luca, Catalina
    Buburuzan, Laura
    Romanescu, Dragos
    Gaina, Gisela
    Stanescu, Codrut
    Sandolache, Bogdan
    Popescu, Irinel
    Botnarciuc, Vladimir
    Costache, Marieta
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2012, 17 (01): : 6921 - 6927
  • [29] The new p53 splice variants p53δ as independent prognostic marker in ovarian carcinoma
    Hofstetter, G.
    Schuster, E.
    Berger, A.
    Wolf, A.
    Marth, C.
    Zeimet, A.
    Concin, N.
    Zeillinger, R.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (05) : 460 - 461
  • [30] An abundance of p53 null mutations in ovarian carcinoma
    Skilling, JS
    Sood, A
    Niemann, T
    Lager, DJ
    Buller, RE
    ONCOGENE, 1996, 13 (01) : 117 - 123